Literature DB >> 24832708

Infant case of lysosomal acid lipase deficiency: Wolman's disease.

Meghmala Sadhukhan1, Amit Saha2, Roshni Vara3, Bim Bhaduri4.   

Abstract

Lysosomal acid lipase (LAL) deficiency is a rare autosomal recessive disorder which causes two distinct clinical phenotypes: Wolman's disease and cholesterol ester storage disease. LAL hydrolyses LDL-derived triglycerides and cholesterol esters to glycerol or cholesterol and free fatty acids. Its deficiency leads to accumulation of intracellular triglycerides and/or cholesterol esters. In early onset LAL deficiency, clinical manifestations start in the first few weeks of life with persistent vomiting, failure to thrive, hepatosplenomegaly, liver dysfunction and hepatic failure. Adrenal calcification is a striking feature but is present in only about 50% of cases. We report a case of an infant presenting with vomiting, diarrhoea, hepatosplenomegaly and poor weight gain that was subsequently diagnosed as Wolman's disease. He was entered into a clinical trial for LAL replacement therapy. This case reinforces that early onset LAL deficiency should be considered in a baby presenting with failure to thrive, gastrointestinal symptoms and hepatosplenomegaly. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24832708      PMCID: PMC4024536          DOI: 10.1136/bcr-2013-202652

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  WOLMAN'S DISEASE: THREE NEW PATIENTS WITH A RECENTLY DESCRIBED LIPIDOSIS.

Authors:  A C CROCKER; G F VAWTER; E B NEUHAUSER; A ROSOWSKY
Journal:  Pediatrics       Date:  1965-04       Impact factor: 7.124

2.  Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant.

Authors:  M WOLMAN; V V STERK; S GATT; M FRENKEL
Journal:  Pediatrics       Date:  1961-11       Impact factor: 7.124

3.  Generalized xanthomatosis with calcified adrenals.

Authors:  A ABRAMOV; S SCHORR; M WOLMAN
Journal:  AMA J Dis Child       Date:  1956-03

Review 4.  Wolman's disease.

Authors:  K J Uniyal; M P Colaco; N S Bharath; M R Pradhan; A K Murthy
Journal:  Indian Pediatr       Date:  1995-02       Impact factor: 1.411

5.  Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.

Authors:  Pietro Vajro; Selvaggia Lenta; Piotr Socha; Anil Dhawan; Patrick McKiernan; Ulrich Baumann; Ozlem Durmaz; Florence Lacaille; Valerie McLin; Valerio Nobili
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-05       Impact factor: 2.839

6.  Wolman disease successfully treated by bone marrow transplantation.

Authors:  W Krivit; C Peters; K Dusenbery; Y Ben-Yoseph; N K Ramsay; J E Wagner; R Anderson
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

7.  Wolman's disease: The King Faisal Specialist Hospital and Research Centre experience.

Authors:  M Al Essa; R Nounou; N Sakati; G Le Quesne; S Joshi; A Archibald; P T Ozand
Journal:  Ann Saudi Med       Date:  1998 Mar-Apr       Impact factor: 1.526

  7 in total
  3 in total

1.  Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2T>G Mutation in Wolman Disease.

Authors:  Carla Ruiz-Andrés; Elena Sellés; Angela Arias; Laura Gort
Journal:  JIMD Rep       Date:  2017-02-21

Review 2.  Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.

Authors:  Francis Aguisanda; Natasha Thorne; Wei Zheng
Journal:  Curr Chem Genom Transl Med       Date:  2017-01-30

Review 3.  Lysosomal acid lipase deficiency in pediatric patients: a scoping review.

Authors:  Camila da Rosa Witeck; Anne Calbusch Schmitz; Júlia Meller Dias de Oliveira; André Luís Porporatti; Graziela De Luca Canto; Maria Marlene de Souza Pires
Journal:  J Pediatr (Rio J)       Date:  2021-05-06       Impact factor: 2.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.